yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38457554-0BEBC4F5-ED55-42F6-A2D0-D9BD248DA36D
Q38457554-0BEBC4F5-ED55-42F6-A2D0-D9BD248DA36D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38457554-0BEBC4F5-ED55-42F6-A2D0-D9BD248DA36D
Tyrosine kinase inhibitor therapy in chronic myeloid leukemia: update on key adverse events.
P2860
Q38457554-0BEBC4F5-ED55-42F6-A2D0-D9BD248DA36D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38457554-0BEBC4F5-ED55-42F6-A2D0-D9BD248DA36D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
69155d5c533c1c37b80a96447cd142e57727df49
P2860
The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity.